Rosetta Genomics Ltd. Payments to Acquire Marketable Securities
Rosetta Genomics Ltd. reported Payments to Acquire Marketable Securities of $0 for the 12-month period ending 2011-12-31, per its 6-K filed 2012-12-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2013-03-22
| Period end | Payments to Acquire Marketable Securities 12 month |
|---|---|
| 2011-12-31 | $0.00 6-K · filed 2012-12-07 |
| 2010-12-31 | $1.49M 20-F · filed 2013-03-22 |
| 2009-12-31 | $4.50M 6-K · filed 2012-12-07 |